A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

Clinical trial NCT06722729 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06722729
Sponsor: Kissei Pharmaceutical Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2024-12-16
Primary completion: 2026-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.